Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Other Accumulated Expenses: 2024

Historic Other Accumulated Expenses for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to $6.4 million.

  • Pyxis Oncology's Other Accumulated Expenses was N/A to $6.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.4 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is N/A change from last year.
  • As of FY2024, Pyxis Oncology's Other Accumulated Expenses stood at $6.4 million.
  • In the past 5 years, Pyxis Oncology's Other Accumulated Expenses registered a high of $6.4 million during FY2024, and its lowest value of $6.4 million during FY2024.
  • For the 1-year period, Pyxis Oncology's Other Accumulated Expenses averaged around $6.4 million, with its median value being $6.4 million (2024).